Aventis Pharmaceuticals conducts the U.S. business of Aventis Pharma AG. With headquarters in Bridgewater, N.J., Aventis Pharmaceuticals focuses its activities on important therapeutic areas such as cardiology, oncology, anti-infectives, arthritis, allergy and respiratory, diabetes, and the central nervous system.

Headquartered in Frankfurt, Germany, Aventis Pharma has key sites in New Jersey, Pennsylvania, France and Japan - and operations in over 50 countries around the world.

The over 9,000 Aventis Pharmaceuticals' associates in the U.S. represent diversity in all of its dimensions, coming from a myriad of races, ethnicities, nationalities, cultures, educational backgrounds, and disciplines, and resulting in a creative mix of ideas and approaches to meeting our business challenges.

We create value through innovative new products. Aventis ranks in the top tier worldwide for commitment to research and development, investing over $2 billion annually in R&D.

Our challenge is life...conquering disease, one person at a time.

http://www.aventis.com